| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxidative Stress | 26 | 2024 | 807 | 5.800 |
Why?
|
| Refugees | 5 | 2024 | 39 | 3.850 |
Why?
|
| Stress, Psychological | 13 | 2022 | 562 | 3.370 |
Why?
|
| Anxiety | 19 | 2021 | 1028 | 2.990 |
Why?
|
| Maze Learning | 14 | 2024 | 99 | 2.500 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2024 | 672 | 2.270 |
Why?
|
| Vitis | 5 | 2017 | 14 | 2.240 |
Why?
|
| Memory Disorders | 12 | 2024 | 207 | 1.980 |
Why?
|
| Sleep Deprivation | 4 | 2019 | 44 | 1.960 |
Why?
|
| Neuroprotective Agents | 4 | 2024 | 161 | 1.850 |
Why?
|
| Vehicle Emissions | 3 | 2021 | 21 | 1.850 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2021 | 1151 | 1.820 |
Why?
|
| Rats | 31 | 2024 | 3460 | 1.690 |
Why?
|
| Behavior, Animal | 11 | 2025 | 510 | 1.680 |
Why?
|
| Hippocampus | 9 | 2024 | 806 | 1.630 |
Why?
|
| Antioxidants | 8 | 2024 | 336 | 1.570 |
Why?
|
| Cyclic N-Oxides | 4 | 2016 | 18 | 1.500 |
Why?
|
| Rats, Wistar | 13 | 2024 | 309 | 1.500 |
Why?
|
| Corticosterone | 12 | 2021 | 53 | 1.380 |
Why?
|
| Hypertension | 6 | 2020 | 1360 | 1.370 |
Why?
|
| Memory | 4 | 2024 | 358 | 1.320 |
Why?
|
| Plant Extracts | 3 | 2017 | 139 | 1.250 |
Why?
|
| Air Pollutants | 2 | 2021 | 126 | 1.080 |
Why?
|
| Brain | 11 | 2021 | 3239 | 1.060 |
Why?
|
| Animals | 52 | 2025 | 34375 | 1.040 |
Why?
|
| Physical Conditioning, Animal | 5 | 2017 | 86 | 1.010 |
Why?
|
| Motor Activity | 5 | 2017 | 508 | 0.930 |
Why?
|
| Dominance-Subordination | 5 | 2017 | 11 | 0.920 |
Why?
|
| Pentoxifylline | 1 | 2024 | 20 | 0.880 |
Why?
|
| Aging | 4 | 2017 | 1265 | 0.870 |
Why?
|
| Disease Models, Animal | 16 | 2025 | 4696 | 0.860 |
Why?
|
| RGS Proteins | 4 | 2015 | 47 | 0.850 |
Why?
|
| beta-Adrenergic Receptor Kinases | 4 | 2007 | 11 | 0.850 |
Why?
|
| Inflammation | 6 | 2019 | 1492 | 0.840 |
Why?
|
| Mental Disorders | 4 | 2024 | 904 | 0.830 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 147 | 0.800 |
Why?
|
| Syria | 4 | 2024 | 12 | 0.800 |
Why?
|
| Mitochondria | 4 | 2020 | 759 | 0.800 |
Why?
|
| Aggression | 2 | 2015 | 221 | 0.790 |
Why?
|
| Social Class | 1 | 2024 | 211 | 0.780 |
Why?
|
| Buthionine Sulfoximine | 4 | 2016 | 9 | 0.760 |
Why?
|
| Brain-Derived Neurotrophic Factor | 7 | 2014 | 97 | 0.760 |
Why?
|
| Students | 2 | 2021 | 251 | 0.740 |
Why?
|
| Rats, Long-Evans | 6 | 2020 | 98 | 0.720 |
Why?
|
| Sex Characteristics | 2 | 2021 | 338 | 0.710 |
Why?
|
| Lactoylglutathione Lyase | 7 | 2017 | 8 | 0.700 |
Why?
|
| Superoxide Dismutase | 6 | 2024 | 179 | 0.690 |
Why?
|
| Academic Success | 1 | 2021 | 22 | 0.690 |
Why?
|
| Propranolol | 2 | 2020 | 111 | 0.680 |
Why?
|
| Memory, Short-Term | 5 | 2015 | 141 | 0.660 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 518 | 0.650 |
Why?
|
| Male | 37 | 2024 | 65266 | 0.640 |
Why?
|
| Nadolol | 1 | 2020 | 12 | 0.640 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2020 | 215 | 0.630 |
Why?
|
| Jordan | 3 | 2024 | 9 | 0.620 |
Why?
|
| Mitochondrial Dynamics | 1 | 2020 | 53 | 0.620 |
Why?
|
| Neurons | 5 | 2021 | 1990 | 0.580 |
Why?
|
| Mental Health | 2 | 2024 | 383 | 0.570 |
Why?
|
| Dinoprost | 5 | 2021 | 25 | 0.560 |
Why?
|
| Resilience, Psychological | 2 | 2017 | 81 | 0.550 |
Why?
|
| Health Impact Assessment | 1 | 2017 | 1 | 0.540 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 226 | 0.540 |
Why?
|
| Neural Pathways | 1 | 2019 | 285 | 0.530 |
Why?
|
| Anxiety Disorders | 2 | 2014 | 744 | 0.530 |
Why?
|
| Social Perception | 1 | 2017 | 54 | 0.520 |
Why?
|
| Visual Perception | 2 | 2017 | 128 | 0.520 |
Why?
|
| Maternal Behavior | 1 | 2017 | 70 | 0.520 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 88 | 0.510 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 106 | 0.500 |
Why?
|
| Air Pollution | 1 | 2017 | 78 | 0.500 |
Why?
|
| Mood Disorders | 1 | 2017 | 132 | 0.490 |
Why?
|
| Catecholamines | 2 | 2021 | 50 | 0.480 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 379 | 0.470 |
Why?
|
| Glutathione Reductase | 5 | 2013 | 10 | 0.470 |
Why?
|
| Fruit | 2 | 2015 | 234 | 0.450 |
Why?
|
| Phytotherapy | 1 | 2015 | 46 | 0.450 |
Why?
|
| Plant Preparations | 1 | 2014 | 15 | 0.440 |
Why?
|
| Spin Labels | 4 | 2016 | 25 | 0.430 |
Why?
|
| Central Nervous System | 1 | 2016 | 286 | 0.430 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 29 | 0.400 |
Why?
|
| Adenylyl Cyclases | 2 | 2004 | 61 | 0.400 |
Why?
|
| Pandemics | 1 | 2021 | 1164 | 0.390 |
Why?
|
| Cognition Disorders | 1 | 2017 | 565 | 0.390 |
Why?
|
| Glutathione | 3 | 2024 | 198 | 0.380 |
Why?
|
| Carbohydrate Metabolism | 3 | 2007 | 51 | 0.380 |
Why?
|
| Social Behavior | 1 | 2014 | 217 | 0.380 |
Why?
|
| Lipid Peroxidation | 2 | 2024 | 91 | 0.370 |
Why?
|
| Depression | 6 | 2017 | 1350 | 0.370 |
Why?
|
| Random Allocation | 4 | 2020 | 423 | 0.370 |
Why?
|
| Spatial Memory | 2 | 2024 | 29 | 0.350 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2011 | 19 | 0.350 |
Why?
|
| Estrogens | 1 | 2013 | 436 | 0.340 |
Why?
|
| Islam | 2 | 2007 | 11 | 0.330 |
Why?
|
| Kidney | 4 | 2020 | 1309 | 0.330 |
Why?
|
| Powders | 3 | 2015 | 26 | 0.330 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2025 | 281 | 0.320 |
Why?
|
| Depressive Disorder | 1 | 2014 | 469 | 0.320 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 2648 | 0.320 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 3834 | 0.310 |
Why?
|
| Exercise Test | 2 | 2013 | 243 | 0.310 |
Why?
|
| Fasting | 2 | 2007 | 303 | 0.300 |
Why?
|
| Cognition | 1 | 2014 | 845 | 0.300 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 2357 | 0.280 |
Why?
|
| Blotting, Western | 6 | 2011 | 1018 | 0.280 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 4050 | 0.270 |
Why?
|
| Humans | 23 | 2025 | 131679 | 0.270 |
Why?
|
| Religion and Medicine | 1 | 2007 | 26 | 0.270 |
Why?
|
| Amyloid beta-Peptides | 4 | 2013 | 236 | 0.260 |
Why?
|
| Oxygen Consumption | 2 | 2020 | 301 | 0.260 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 4 | 2003 | 10 | 0.260 |
Why?
|
| Female | 11 | 2024 | 71185 | 0.260 |
Why?
|
| Homeostasis | 1 | 2011 | 713 | 0.250 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 39 | 0.250 |
Why?
|
| Diet | 1 | 2013 | 1121 | 0.250 |
Why?
|
| Housing, Animal | 2 | 2017 | 19 | 0.240 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 240 | 0.240 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 5 | 2011 | 9 | 0.230 |
Why?
|
| Insulin Resistance | 1 | 2010 | 681 | 0.230 |
Why?
|
| Immunomodulation | 1 | 2025 | 80 | 0.230 |
Why?
|
| Streptozocin | 1 | 2024 | 26 | 0.220 |
Why?
|
| Glutathione Peroxidase | 1 | 2024 | 48 | 0.220 |
Why?
|
| Spleen | 1 | 2025 | 256 | 0.220 |
Why?
|
| Aerosols | 1 | 2024 | 60 | 0.220 |
Why?
|
| Vitamin E | 1 | 2024 | 63 | 0.220 |
Why?
|
| Exploratory Behavior | 2 | 2017 | 53 | 0.210 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2024 | 14 | 0.210 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2024 | 59 | 0.200 |
Why?
|
| Darkness | 2 | 2015 | 25 | 0.200 |
Why?
|
| Time Factors | 6 | 2015 | 6279 | 0.200 |
Why?
|
| Educational Status | 1 | 2024 | 281 | 0.200 |
Why?
|
| Texas | 2 | 2022 | 3622 | 0.200 |
Why?
|
| Long-Term Potentiation | 3 | 2013 | 105 | 0.190 |
Why?
|
| Stress, Physiological | 2 | 2015 | 262 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2011 | 4683 | 0.190 |
Why?
|
| Amygdala | 2 | 2015 | 86 | 0.190 |
Why?
|
| Nanoparticles | 1 | 2025 | 292 | 0.190 |
Why?
|
| Brain Chemistry | 2 | 2013 | 111 | 0.180 |
Why?
|
| Cell Line | 3 | 2016 | 2605 | 0.180 |
Why?
|
| Alzheimer Disease | 4 | 2013 | 875 | 0.180 |
Why?
|
| Lipids | 1 | 2025 | 565 | 0.180 |
Why?
|
| Microvilli | 4 | 2007 | 65 | 0.180 |
Why?
|
| Bromine | 1 | 2021 | 3 | 0.180 |
Why?
|
| Epinephrine | 3 | 2014 | 150 | 0.180 |
Why?
|
| Cell Survival | 2 | 2016 | 854 | 0.170 |
Why?
|
| Xanthine | 2 | 2011 | 6 | 0.170 |
Why?
|
| Models, Animal | 3 | 2015 | 460 | 0.170 |
Why?
|
| Xanthine Oxidase | 2 | 2011 | 39 | 0.170 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 222 | 0.170 |
Why?
|
| Histones | 2 | 2014 | 518 | 0.170 |
Why?
|
| Health Status | 1 | 2023 | 388 | 0.170 |
Why?
|
| Analysis of Variance | 3 | 2013 | 955 | 0.170 |
Why?
|
| Faculty | 1 | 2021 | 98 | 0.160 |
Why?
|
| Brain Stem | 1 | 2021 | 112 | 0.160 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 38 | 0.160 |
Why?
|
| Perception | 1 | 2022 | 229 | 0.160 |
Why?
|
| Carrier Proteins | 3 | 2000 | 1024 | 0.160 |
Why?
|
| Universities | 1 | 2021 | 122 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2024 | 1104 | 0.160 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 26 | 0.160 |
Why?
|
| Teaching | 1 | 2021 | 196 | 0.160 |
Why?
|
| Superoxides | 1 | 2020 | 129 | 0.160 |
Why?
|
| Nitric Oxide Synthase | 1 | 2020 | 168 | 0.160 |
Why?
|
| Locus Coeruleus | 2 | 2011 | 21 | 0.150 |
Why?
|
| Calpain | 2 | 2011 | 41 | 0.150 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 2 | 2011 | 5 | 0.150 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 749 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 418 | 0.150 |
Why?
|
| Locomotion | 1 | 2019 | 59 | 0.150 |
Why?
|
| Estradiol | 1 | 2021 | 481 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2021 | 317 | 0.140 |
Why?
|
| Young Adult | 2 | 2024 | 10104 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2013 | 832 | 0.140 |
Why?
|
| Mice | 6 | 2025 | 18488 | 0.140 |
Why?
|
| CA1 Region, Hippocampal | 3 | 2013 | 71 | 0.140 |
Why?
|
| Gene Expression | 2 | 2013 | 1502 | 0.140 |
Why?
|
| Drinking | 1 | 2017 | 28 | 0.130 |
Why?
|
| Blood Pressure | 2 | 2013 | 1344 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2022 | 1454 | 0.130 |
Why?
|
| Psychological Tests | 1 | 2017 | 94 | 0.130 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 160 | 0.130 |
Why?
|
| Kidney Cortex | 4 | 2007 | 19 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 227 | 0.130 |
Why?
|
| Phosphates | 3 | 2007 | 110 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1236 | 0.120 |
Why?
|
| Isoprostanes | 1 | 2015 | 4 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 46 | 0.120 |
Why?
|
| Cell Shape | 1 | 2016 | 70 | 0.120 |
Why?
|
| Postpartum Period | 1 | 2017 | 235 | 0.120 |
Why?
|
| Equipment Design | 1 | 2017 | 555 | 0.120 |
Why?
|
| Immune System | 1 | 2016 | 98 | 0.120 |
Why?
|
| Memory, Long-Term | 1 | 2015 | 35 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 566 | 0.120 |
Why?
|
| Animals, Newborn | 1 | 2019 | 1024 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 99 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2022 | 904 | 0.110 |
Why?
|
| Infusion Pumps | 1 | 2015 | 31 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 265 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2015 | 54 | 0.110 |
Why?
|
| Protein Carbonylation | 2 | 2011 | 6 | 0.110 |
Why?
|
| Adolescent | 2 | 2024 | 20982 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2014 | 156 | 0.110 |
Why?
|
| Neuroimmunomodulation | 1 | 2014 | 15 | 0.110 |
Why?
|
| Anhedonia | 1 | 2014 | 36 | 0.100 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 119 | 0.100 |
Why?
|
| Social Dominance | 1 | 2013 | 11 | 0.100 |
Why?
|
| Cell Membrane | 3 | 2006 | 464 | 0.100 |
Why?
|
| Acetylation | 1 | 2014 | 181 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 387 | 0.100 |
Why?
|
| Deoxyguanosine | 1 | 2013 | 12 | 0.100 |
Why?
|
| Food, Preserved | 1 | 2013 | 1 | 0.100 |
Why?
|
| Freeze Drying | 1 | 2013 | 15 | 0.100 |
Why?
|
| Emotions | 1 | 2016 | 367 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2013 | 38 | 0.100 |
Why?
|
| Dopamine | 1 | 2014 | 256 | 0.100 |
Why?
|
| Polyphenols | 1 | 2013 | 24 | 0.100 |
Why?
|
| Body Weight | 1 | 2017 | 990 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 288 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 2564 | 0.100 |
Why?
|
| Ovariectomy | 1 | 2013 | 163 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 98 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 2004 | 229 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 138 | 0.090 |
Why?
|
| Molecular Sequence Data | 5 | 2004 | 3616 | 0.090 |
Why?
|
| Learning | 2 | 2013 | 369 | 0.090 |
Why?
|
| Adult | 2 | 2024 | 31719 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2025 | 466 | 0.090 |
Why?
|
| DNA, Antisense | 1 | 2011 | 8 | 0.090 |
Why?
|
| Predatory Behavior | 1 | 2011 | 8 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2011 | 589 | 0.090 |
Why?
|
| Oxidants | 1 | 2011 | 25 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2011 | 49 | 0.090 |
Why?
|
| Amnesia | 1 | 2011 | 19 | 0.090 |
Why?
|
| Helplessness, Learned | 1 | 2011 | 8 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2007 | 2568 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 125 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2011 | 114 | 0.080 |
Why?
|
| Biomarkers | 3 | 2021 | 3405 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 3673 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 117 | 0.080 |
Why?
|
| Light | 1 | 2011 | 174 | 0.080 |
Why?
|
| Kidney Medulla | 2 | 2007 | 19 | 0.080 |
Why?
|
| Ischemia | 3 | 2005 | 355 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 997 | 0.080 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 99 | 0.080 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 18 | 0.080 |
Why?
|
| Malondialdehyde | 1 | 2010 | 49 | 0.080 |
Why?
|
| Ganglionic Stimulants | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2971 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 792 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2013 | 453 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 2363 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2011 | 419 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 643 | 0.070 |
Why?
|
| Nicotine | 1 | 2009 | 117 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2011 | 659 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 741 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2013 | 138 | 0.070 |
Why?
|
| Biological Transport, Active | 1 | 2007 | 73 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2004 | 595 | 0.070 |
Why?
|
| Transcription Factor AP-2 | 1 | 2007 | 22 | 0.070 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2007 | 63 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 37 | 0.070 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2007 | 51 | 0.070 |
Why?
|
| Benzophenanthridines | 1 | 2007 | 3 | 0.070 |
Why?
|
| Phentolamine | 1 | 2007 | 16 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2021 | 47 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2007 | 18 | 0.060 |
Why?
|
| Ionomycin | 1 | 2006 | 15 | 0.060 |
Why?
|
| Benzoquinones | 1 | 2006 | 19 | 0.060 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 40 | 0.060 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 33 | 0.060 |
Why?
|
| Enzyme Stability | 1 | 2006 | 58 | 0.060 |
Why?
|
| Alkaloids | 1 | 2007 | 36 | 0.060 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2007 | 26 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2007 | 79 | 0.060 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2007 | 51 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 191 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 420 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2003 | 216 | 0.060 |
Why?
|
| Kinetics | 3 | 2005 | 1101 | 0.060 |
Why?
|
| Binding Sites | 3 | 2003 | 1202 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2025 | 73 | 0.060 |
Why?
|
| United States | 1 | 2021 | 11804 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 316 | 0.060 |
Why?
|
| Liposomes | 1 | 2025 | 200 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 109 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2006 | 287 | 0.050 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 2004 | 3 | 0.050 |
Why?
|
| Middle Aged | 1 | 2024 | 28888 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2004 | 22 | 0.050 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2003 | 8 | 0.050 |
Why?
|
| Proteinuria | 1 | 2024 | 106 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2003 | 286 | 0.050 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2006 | 49 | 0.050 |
Why?
|
| Adenylyl Cyclase Inhibitors | 1 | 2003 | 5 | 0.050 |
Why?
|
| Calcineurin | 2 | 2013 | 59 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 88 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2006 | 93 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 32 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17667 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 709 | 0.050 |
Why?
|
| Electric Stimulation | 2 | 2013 | 249 | 0.040 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2021 | 32 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2003 | 257 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2021 | 107 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2021 | 192 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 142 | 0.040 |
Why?
|
| Acyl Coenzyme A | 1 | 2000 | 23 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2000 | 27 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 260 | 0.040 |
Why?
|
| Cytokines | 1 | 2025 | 1348 | 0.040 |
Why?
|
| Synaptic Transmission | 2 | 2013 | 329 | 0.040 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 1999 | 18 | 0.040 |
Why?
|
| Liver | 1 | 2006 | 1799 | 0.040 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 2 | 2011 | 7 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 442 | 0.040 |
Why?
|
| Reperfusion | 3 | 2005 | 26 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 786 | 0.040 |
Why?
|
| Metabolome | 1 | 2021 | 329 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12984 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2021 | 711 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4769 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4516 | 0.030 |
Why?
|
| Apoptosis | 1 | 1999 | 1861 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 211 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 418 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 781 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 59 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2009 | 132 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1571 | 0.020 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2006 | 3 | 0.020 |
Why?
|
| Leucyl Aminopeptidase | 1 | 2006 | 3 | 0.020 |
Why?
|
| Malate Dehydrogenase | 1 | 2006 | 5 | 0.020 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2006 | 17 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 2006 | 12 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2006 | 62 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2006 | 25 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2006 | 9 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2005 | 56 | 0.010 |
Why?
|
| Phosphorus | 1 | 2005 | 61 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2005 | 56 | 0.010 |
Why?
|
| Proline | 1 | 2005 | 84 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 261 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 333 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 362 | 0.010 |
Why?
|
| Sodium | 1 | 2005 | 281 | 0.010 |
Why?
|
| Renal Circulation | 1 | 2004 | 41 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 960 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2004 | 65 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 249 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 252 | 0.010 |
Why?
|
| Steroids | 1 | 2003 | 172 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1712 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1087 | 0.010 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 1999 | 4 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 88 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 846 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 625 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 209 | 0.010 |
Why?
|
| Phospholipids | 1 | 1997 | 103 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 402 | 0.010 |
Why?
|
| Cholesterol | 1 | 1997 | 541 | 0.010 |
Why?
|